I don't care if all United States "legal ethics" professors vetted this settlement. I think it stinks for the plaintiffs and shows the plaintiffs' attorneys were not their fiduciaries. On 9 November Merck announced the settlement. On that day, Merck stock rose $1.13 per share. With 210 million shares outstanding, the market concluded that the settlement was good for Merck, to the tune of $2.5 billion. Who do these plaintiffs' lawyers really work for?
See my 29 September post quoting Lester Brinkman. That judges will supervise the withdrawals does nothing for me.